<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000589422"><TermName>Avage</TermName><TermPronunciation>(AY-vazh)</TermPronunciation><TermDefinition><DefinitionText>A drug used on the skin to treat several skin conditions. It is also being studied in the treatment of basal cell skin cancer and basal cell nevus syndrome. Avage is related to vitamin A and is made in the laboratory. It turns on a gene that may help stop the growth of skin cancer cells. Avage is a type of synthetic retinoid. Also called tazarotene and Tazorac.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000721144" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Avage&quot;" language="en" id="_3"/><MediaLink ref="CDR0000721143" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Avage&quot;" language="es" id="_4"/><SpanishTermName>Avage</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se aplica sobre la piel para tratar varias afecciones cutáneas. Asimismo, está en estudio para el tratamiento de cáncer de la piel de células basales y el síndrome de nevo de células basales. Avage se relaciona con la vitamina A y se produce en el laboratorio. Estimula un gen que puede ayudar a detener el crecimiento de las células cancerosas de la piel. Avage es un tipo de retinoide sintético. También se llama tazaroteno y Tazorac.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-03-10</DateFirstPublished></GlossaryTerm>
